Santhera Pharmaceuticals Holding Balance Sheet Health
Financial Health criteria checks 5/6
Santhera Pharmaceuticals Holding has a total shareholder equity of CHF48.1M and total debt of CHF23.7M, which brings its debt-to-equity ratio to 49.2%. Its total assets and total liabilities are CHF108.2M and CHF60.2M respectively. Santhera Pharmaceuticals Holding's EBIT is CHF53.7M making its interest coverage ratio 3.3. It has cash and short-term investments of CHF16.5M.
Key information
49.2%
Debt to equity ratio
CHF 23.67m
Debt
| Interest coverage ratio | 3.3x |
| Cash | CHF 16.49m |
| Equity | CHF 48.06m |
| Total liabilities | CHF 60.19m |
| Total assets | CHF 108.25m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SANNZ's short term assets (CHF33.6M) do not cover its short term liabilities (CHF53.1M).
Long Term Liabilities: SANNZ's short term assets (CHF33.6M) exceed its long term liabilities (CHF7.1M).
Debt to Equity History and Analysis
Debt Level: SANNZ's net debt to equity ratio (14.9%) is considered satisfactory.
Reducing Debt: SANNZ's debt to equity ratio has reduced from 649.6% to 49.2% over the past 5 years.
Debt Coverage: SANNZ's debt is well covered by operating cash flow (200.1%).
Interest Coverage: SANNZ's interest payments on its debt are well covered by EBIT (3.3x coverage).